Pursuant to regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 Sandu Pharmaceuticals has informed about the issue of the duplicate share certificate to the shareholder(s), Rukmanibai Tillumak Manghnan (Folio No: 000236, 000266). Further details of the same as enclosed.
The above information is a part of company’s filings submitted to BSE.